Concentra

Intellihealth Hires Annie Lorenzo as Executive VP of Clinical Operations

Retrieved on: 
Tuesday, February 6, 2024

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Intellihealth, a leading provider of healthcare technology and clinical services that deliver a comprehensive and clinically proven medical model for treating obesity, has hired Annie Lorenzo as executive vice president of clinical operations. Lorenzo will be responsible for providing strategic leadership and day-to-day management of all clinical operations personnel and will play a pivotal role in strengthening the Flyte organization as Intellihealth scales its offerings across the country.

Key Points: 
  • NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Intellihealth , a leading provider of healthcare technology and clinical services that deliver a comprehensive and clinically proven medical model for treating obesity, has hired Annie Lorenzo as executive vice president of clinical operations.
  • Lorenzo will be responsible for providing strategic leadership and day-to-day management of all clinical operations personnel and will play a pivotal role in strengthening the Flyte organization as Intellihealth scales its offerings across the country.
  • "We are delighted to welcome Annie to the Intellihealth team," said Sloan Saunders, Intellihealth CEO.
  • At Babylon, she scaled and led the operations of a large multi-speciality clinical network serving medicaid members in global value-based risk agreements.

Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals

Retrieved on: 
Tuesday, January 30, 2024

Pursuant to the Merger Agreement, on January 9, 2024, Purchaser and Parent commenced a tender offer to acquire all outstanding shares of Theseus common stock (the “Offer”).

Key Points: 
  • Pursuant to the Merger Agreement, on January 9, 2024, Purchaser and Parent commenced a tender offer to acquire all outstanding shares of Theseus common stock (the “Offer”).
  • Stockholders that have previously tendered their shares do not need to re-tender their shares or take any other action in response to the determination of the Additional Price Per Share or extension of the Offer expiration date.
  • As previously announced, Theseus stockholders holding approximately 59% of Theseus common stock have signed support agreements to tender their shares in the Offer prior to the expiration date and support the merger.
  • In addition, Theseus’ stockholders may obtain free copies of the Offer materials by contacting Morrow Sodali LLC, the information agent for the Offer.

Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2023 Results on Thursday, February 22, 2024

Retrieved on: 
Monday, January 22, 2024

MECHANICSBURG, Pa., Jan. 22, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 after the market closes.

Key Points: 
  • MECHANICSBURG, Pa., Jan. 22, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 after the market closes.
  • Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 23, 2024, at 9:00am ET.
  • The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com .
  • At December 31, 2023, Select Medical had operations in 46 states and the District of Columbia.

Harlan Law and Hillier DiGiacco LLP Obtain $9.37 Million Verdict Against National Healthcare Conglomerate

Retrieved on: 
Monday, January 8, 2024

This verdict follows more than three years of intensive investigation and litigation, and delivers to Plaintiff Marilyn Buron, long-awaited justice.

Key Points: 
  • This verdict follows more than three years of intensive investigation and litigation, and delivers to Plaintiff Marilyn Buron, long-awaited justice.
  • Marilyn alerted her supervisors at Concentra and took job protected leave from December 1, 2020 through February 22, 2021.
  • According to attorney Jordon Harlan, "At each step of this process, Concentra refused to accept responsibility for violating the law.
  • The jury also awarded $7,810,000 in punitive damages against Concentra to prevent them from ever doing this to anyone again.

THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders

Retrieved on: 
Friday, December 22, 2023

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) to Concentra Biosciences, LLC for between $3.90 and $4.05 in cash is fair to Theseus shareholders.

Key Points: 
  • Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) to Concentra Biosciences, LLC for between $3.90 and $4.05 in cash is fair to Theseus shareholders.
  • On behalf of Theseus shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.
  • Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Nox Health Expands Board of Directors

Retrieved on: 
Wednesday, November 1, 2023

ALPHARETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of three new board members: Lloyd Dean, Chief Executive Emeritus & Founding Executive, CommonSpirit Health; David Schlanger, Executive Chairman, Progyny; Dr. Bill Lewis, Telehealth Consultant to Fortune 500 companies.

Key Points: 
  • ALPHARETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of three new board members: Lloyd Dean, Chief Executive Emeritus & Founding Executive, CommonSpirit Health; David Schlanger, Executive Chairman, Progyny; Dr. Bill Lewis, Telehealth Consultant to Fortune 500 companies.
  • “Sleep is the missing gap in care central to all chronic conditions,” said Sigurjon Kristjanson, CEO Nox Health.
  • He led CommonSpirit Health and Dignity Health through significant strategic, operational, and financial transformations to its current status as a leading health care organization recognized for high quality, compassionate care, operational excellence and successful financial results.
  • Dr. Bill Lewis commented: “I am proud to join the Board of Directors of Nox Health, a purpose-driven company that is focused on enabling access and improving outcomes, issues that I have dedicated my career to addressing.”

Select Medical Holdings Corporation to Announce Third Quarter 2023 Results on Thursday, November 2, 2023

Retrieved on: 
Wednesday, October 4, 2023

MECHANICSBURG, Pa., Oct. 4, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2023 on Thursday, November 2, 2023 after the market closes.

Key Points: 
  • MECHANICSBURG, Pa., Oct. 4, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2023 on Thursday, November 2, 2023 after the market closes.
  • Select Medical will host a conference call regarding its third quarter results, as well as its business outlook, on Friday, November 3, 2023, at 9:00am ET.
  • The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com .
  • At June 30, 2023, Select Medical had operations in 46 states and the District of Columbia.

Select Medical Holdings Corporation to Announce Second Quarter 2023 Results on Thursday, August 3, 2023

Retrieved on: 
Friday, July 7, 2023

MECHANICSBURG, Pa., July 7, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2023 on Thursday, August 3, 2023 after the market closes.

Key Points: 
  • MECHANICSBURG, Pa., July 7, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2023 on Thursday, August 3, 2023 after the market closes.
  • Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 4, 2023, at 9:00am ET.
  • The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com .
  • At March 31, 2023, Select Medical had operations in 46 states and the District of Columbia.

MIMEDX Appoints Doug Rice as Chief Financial Officer

Retrieved on: 
Wednesday, July 5, 2023

MARIETTA, Ga., July 05, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has appointed Doug Rice as the Company’s Chief Financial Officer, effective today.

Key Points: 
  • MARIETTA, Ga., July 05, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has appointed Doug Rice as the Company’s Chief Financial Officer, effective today.
  • Pete Carlson, who has served in that role since March 2020, has resigned as Chief Financial Officer, also effective today.
  • Mr. Rice is a Certified Public Accountant and received his BBA with honors and his MBA from Southern Methodist University.
  • “We are excited to welcome Doug to the MIMEDX team,” stated Joe Capper, MIMEDX’s Chief Executive Officer.

National Safety Council Commemorates MSD Pledge Anniversary by Sharing Insights and Actions Along the Journey to Reducing the Most Common Workplace Injury

Retrieved on: 
Thursday, June 15, 2023

WASHINGTON, June 15, 2023 /PRNewswire/ -- Musculoskeletal disorders, or MSDs, are the most common workplace injury and the leading cause of worker disability, involuntary retirement and limitations to gainful employment. In addition to the impact these injuries have on employee wellbeing, they also cost businesses in the private sector nearly $17 billion a year. Recognizing the significance of this issue, the National Safety Council launched the MSD Pledge last June to reduce this pervasive safety challenge. Today, more than 160 of the world's top organizations have joined the global movement to transform workplace safety and improve the lives of millions of workers. 

Key Points: 
  • Recognizing the significance of this issue, the National Safety Council launched the MSD Pledge last June to reduce this pervasive safety challenge.
  • To commemorate this milestone, the Council's MSD Solutions Lab , a groundbreaking initiative established in 2021 with funding from Amazon (NASDAQ: AMZN) to solve workplace MSDs, Thursday hosted its second annual Workplace Safety Summit: Insights and Actions to Prevent the Most Common Injury on the Job.
  • The MSD Pledge is one of several initiatives underway by the MSD Solutions Lab to solve MSDs before they start, including an advisory council, MSD pioneering research, innovation challenges, and grant program.
  • To learn more about the MSD Pledge, the MSD Solutions Lab, and the risks associated with MSDs, visit www.nsc.org/msd .